Abstract
Low folate intake in the presence of the functional MTHFR 677 C > T (rs1801133) polymorphism is an important cause of elevated homocysteine levels previously implicated in major depressive disorder (MDD) and many other chronic diseases. In this study the clinical relevance and inter-relationship of these aspects were evaluated in 86 South African patients diagnosed with MDD and 97 population-matched controls participating in a chronic diseases screening program. A questionnaire-based clinical and nutrition assessment was performed, homocysteine levels determined, and all study participants genotyped for MTHFR 677 C > T (rs1801133) using allele-specific TaqMan technology. The folate score was found to be significantly lower in the patient group compared to controls (p = 0.003) and correlated with increased body mass index (BMI), particularly in females with MDD (p = 0.009). BMI was significantly higher in the MDD patients compared with controls after adjustment for age and sex (p = 0.015), but this association was no longer significant after further adjustment for the level of folate intake in the diet. In MDD patients but not controls, the minor T-allele of MTHFR 677 C > T was associated with increased BMI (p = 0.032), which in turn correlated significantly with increased homocysteine levels. The significant association between BMI and homocysteine levels was observed in both the MDD patient (p = 0.049) and control (p = 0.018) study groups. The significantly higher homocysteine levels observed in MDD patients compared to controls after adjustment for age and sex (p = 0.030), therefore appears to be mediated by the effects of MTHFR 677 C > T and low folate intake on BMI. Detection of the low-penetrance MTHFR 677 C > T mutation reinforces the importance of folate intake above the recommended daily dose to prevent or restore dysfunction of the methylation pathway.
Similar content being viewed by others
References
Abou-Saleh MT, Coppen A (2006) Folic acid and the treatment of depression. J Psychosom Res 61:285–287
Almeida OP, McCaul K, Hankey GJ, Norman P, Jamrozik K, Flicker L (2008) Homocysteine and depression in later life. Arch Gen Psychiatry 65:1286–1294
Alpert JE, Fava M (1997) Nutrition and depression: the role of folate. Nutr Rev 55:145–148
Bailey LB, Gregory JF III (1999) Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr 129:919–22
Bjelland I, Tell GS, Vollset ES et al (2003) Folate, vitamin B12 homocysteine and the MTHFR 677C to T polymorphism in anxiety and depression. Arch Gen Psychiatry 60:618–626
Bottiglieri T (2005) Homocysteine and folate metabolism in depression. Prog Neuropsychoparmacol Biol Psychiatry 29:1103–1112
Coppen A, Bailey J (2000) Enhancement of the antidepressant action of fluoxetine by folic acid: a randomized, placebo controlled trial. J Affect Disord 60:121–130
Coppen A, Bolander-Gouaille C (2005) Treatment of depression: time to consider folic acid and vitamin B12. J Psychopharmacol 19:59–65
Davis W, van Rensburg SJ, Cronje FJ, Whati L, Fisher L, van der Merwe L, Geiger D, Hassan MS, Matsha T, Erasmus RT, Kotze MJ (2014) The fat mass and obesity-associated FTO rs9939609 polymorphism is associated with elevated homocysteine levels in patients with multiple sclerosis screened for vascular risk factors. Met Brain Dis. doi:10.1007/s11011-014-9486-7
Devlin AM, Ngai YF, Ronsley R, Panagiotopoulous C (2012) Cardio metabolic risk and the MTHFR C677T variant in children treated with second generation antipsychotics. Transl Psychiatry 2:1–7
Di Renzo L, Rizzo M, Iacopino L, Sarlo F, Domino E, Jacoangeli F, Colica C, Sergi D, De Lorenzo A (2013) Body composition phenotype: Italian Mediterranean diet and C677T MTHFR gene polymorphism interaction. Eur Rev Med Pharmacol Sci 17:2555–2565
Dimopoulos N (2007) Correlation of folate, vitamin B12 and homocysteine plasma levels with depression in an elderly Greek population. Clin Biochem 40:604–608
Fava M, Mischoulon D (2009) Folate in depression: efficacy, safety, differences in formulations, and clinical issues. J Clin Psychiatry 5:7012–7017
Gilbody S, Lewis S, Lightfoot T (2007) Methylenetetrahydrofolatereductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol 165:1–13
Gu P, Defina LF, Leonard D, John S, Weiner MF, Brown ES (2012) Relationship between serum homocysteine levels and depressive symptoms: the Cooper Center longitudinal study. J Clin Psychiatry 73:691–695
Gurwitz D, Weizman A (2004) Personalized psychiatry: a realistic goal. Pharmacogenomics 5:213–217
Herrmann W, Obeid R, Schorr H et al (2003) Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and the B-vitamins: a facet of nature-nurture interplay. Clin Chem Lab Med 41:547–553
Hulot JS (2010) Pharmacogenomics and personalized medicine: lost in translation? Genome Med 2:1–4
Kao AC, Müller DJ (2013) Genetics of antipsychotic-induced weight gain: update and current perspectives. Pharmacogenomics 14:2067–2083
Khoury MJ, Gwinn M, Ioannidis JP (2010) The emergence of translational epidemiology: from scientific discovery to population health impact. Am J Epidemiol 172:517–524
Kolb AF, Petrie L (2013) Folate deficiency enhances the inflammatory response of macrophages. Mol Immunol 54:64–172
Kotze MJ, van Rensburg SJ (2012) Pathology supported genetic testing and treatment of cardiovascular disease in middle age for prevention of Alzheimer’s disease. Metab Brain Dis 27:255–266
Kotze MJ, Schorn D, Coetzer P (2004) The impact of genetic testing on life insurance. J Genomics Afr Soc 1:1–11
Kotze MJ, van Velden DP, Botha K, Badenhorst CH, Avenant H, van Rensburg SA, Cronje FJ (2013) Pathology-supported genetic testing directed at shared disease pathways for optimized health in later life. Personalized Med 10:497–507
Lesch KP (2004) Gene-environment interaction and the genetics of depression. J Psychiatry Neurosci 29:174–184
Li X, Sundquist J, Sundquist K (2008) Age-specific familial risks of depression: a nation-wide epidemiological study from Sweden. J Psychiatr Res 42:808–814
Luk JW, Tosh JY (2010) Moderation of gender on smoking and depression in Chinese Americans. Addict Behav 35:1040–1043
Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BWJH, Zitman FG (2010) Overweight, obesity and depression. Arch Gen Psychiatry 67:220–229
Marini NJ, Gin J, Ziegle J, Keho KH, Ginzinger D, Gilbert DA, Rine J (2008) The prevalence of folate-remedial MTHFR enzyme variants in humans. Proc Natl Acad Sci U S A 105:8055–8060
Mojtabai R (2004) Body mass index and serum folate in childbearing age women. Eur J Epidemiol 19:1029–1036
Moriyama Y, Okamura T, Kajinami K et al (2002) Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese. Atherosclerosis 164:321–328
Nelson JG (2012) The evolving story of folate in depression and therapeutic potential of L-methylfolate. Am J Psychiatry 169:1223–1225
Papakostas GI, Cassiello CF, Lovieno N (2012) Folates and S-adenosylmethionine for major depressive disorder. Can J Psychiatry 57:406–413
Pasco JA, Williams LJ, Jacka FN, Ng F, Henry MJ, Nicholson GC, Kotowicz MA, Berk M (2008) Tobacco smoking as a risk factor for major depressive disorder: population-based study. Br J Psychiatry 193:322–326
Peerbooms OL, van Os J, Drukker M, Kenis G, Hoogveld L, MTHFR in Psychiatry Group, de Hert M, Delespaul P, van Winkel R, Rutten BP (2011) Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability? Brain Behav Immun 25:1530–1543
Pouyanne P, Haramburu F, Imbs JL, Begaud B (2000) Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. Br Med J 320:1036
Samaan Z, Gaysina D, Cohen-Woods S, Craddock N, Jones L, Korszun A, Owen M, Mente A, McGuffin P, Farmer A (2011) Methylenetetrahydrofolate reductase gene variant (MTHFR C677T) and migraine: a case control study and meta-analysis. BMC Neurol 11:66–75
Stahl SM (2010) Enhancing outcomes from major depression: using antidepressant combination therapies with multifunctional pharmacologic mechanisms from the initiation of treatment. CNS Spectr 15:79–94
Sugden C (2006) One-carbon metabolism in psychiatric illness. Nutr Res Rev 19:117–136
Sullivan PF, Neale MC, Kendler KS (2000) Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 157:1552–1562
Tiemeier H, van Tuijl HR, Hofman A, Meijer J, Kiliaan AJ, Breteler MM (2002) Vitamin B12, folate, and homocysteine in depression: the rotterdam study. Am J Psychiatry 159:2099–2101
Tomlinson M, Grimsrud AT, Stein DJ, Williams DR, Myer L (2009) The epidemiology of major depression in South Africa: results from the South African stress and health study. S Afr Med J 99:367–373
Wilkinson G (2005) Drug metabolism and variability among patients in drug response. N Engl J Med 352:2211–2221
Wu YL, Ding XX, Sun YH, Yang HY, Chen J, Zhao X, Jiang YH, Lv XL, Wu ZQ (2013) Association between MTHFR C677T polymorphism and depression: an updated meta-analysis of 26 studies. Prog Neuropsychopharmacol Biol Psychiatry 46:78–85
Young SN (2007) Folate and depression - a neglected problem. J Psychiatry Neurosci 32:80–82
Acknowledgments
We gratefully acknowledge the financial support from Winetech and the Technology for Human Resources and Industry Program (THRIP). The MRC Biostatistics Unit is acknowledged for statistics support. Drs Karien Botha and Hilmar Luckhoff are thanked for providing clinical support and Lindiwe Whati for development of the nutrition and lifestyle questionnaire.
Disclosure
Prof Kotze is a director and shareholder of Gknowmix (Pty) Ltd. that has developed a database tool for research translation under the auspices of the Innovation Centre of the South African Medical Research Council. The other authors declared no conflict of interest and no writing assistance was obtained in the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Delport, D., Schoeman, R., van der Merwe, N. et al. Significance of dietary folate intake, homocysteine levels and MTHFR 677 C>T genotyping in South African patients diagnosed with depression: test development for clinical application. Metab Brain Dis 29, 377–384 (2014). https://doi.org/10.1007/s11011-014-9506-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-014-9506-7